COVID‐19 Outcomes and Vaccination Response Among Patients With Psoriasis Receiving Biologics
Dermatologic Therapy · 2026-01 · 2026 (1)
DOI: 10.1155/dth/2037939 ↗Kurz gefasst
Fachartikel in der Zeitschrift Dermatologic Therapy, online erschienen am 09.06.2026. Verfasst von Danielle Bar und 3 weiteren Autor:innen. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Biologic therapy in psoriasis raises concerns regarding COVID‐19 infection risk and vaccine response, yet real‐world data remain limited.
Objective
To evaluate COVID‐19 infection rates, clinical severity, and vaccination response among biologic‐treated patients with psoriasis during the COVID‐19 pandemic.
Methods
This cohort study included 12,306 patients with psoriasis followed at a tertiary medical center between March 2020 and May 2023. Primary outcomes included estimated SARS‐CoV‐2 infection rates, hospitalization, ICU admission, mortality, and a composite severe COVID‐19 outcome (hospitalization, ICU admission, or death).
Results
Based on national seroprevalence‐adjusted rates, infection occurred in 673 of 962 biologic‐treated patients (70.0%) and 7657 of 11,344 nonbiologic patients (67.5%) ( p = 0.18). Hospitalization was more frequent among biologic‐treated patients (45.2% vs 25.1%; p < 0.001), while ICU admission rates were comparable (2.6% vs 2.0%; p = 0.41). Mortality was significantly lower in the biologic group (6.3% vs 12.1%; p < 0.001).
Conclusions
Biologic therapy in psoriasis was not associated with increased susceptibility to SARS‐CoV‐2 infection or impaired vaccine response.
Zitieren
APA
Bar, D., Pavlotsky, F., Barzilai, A., & Baum, S. (2026). COVID‐19 Outcomes and Vaccination Response Among Patients With Psoriasis Receiving Biologics. Dermatologic Therapy, 2026(1). https://doi.org/10.1155/dth/2037939
Vancouver
Bar D, Pavlotsky F, Barzilai A, Baum S. COVID‐19 Outcomes and Vaccination Response Among Patients With Psoriasis Receiving Biologics. Dermatologic Therapy. 2026;2026(1). doi:10.1155/dth/2037939
BibTeX
@article{Bar2026,
author = {Bar, Danielle and Pavlotsky, Felix and Barzilai, Aviv and Baum, Sharon},
title = {COVID‐19 Outcomes and Vaccination Response Among Patients With Psoriasis Receiving Biologics},
journal = {Dermatologic Therapy},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/dth/2037939}
}
EUVIMED